Smith & Nephew Pays $240M For Integra’s Extremities Business
Executive Summary
Integra is divesting its underperforming extremity orthopedics product portfolio to focus on its neurosurgery, surgical instrument and regenerative medicine businesses.
You may also be interested in...
Orthopedic Roundup Q1: COVID-19’s Stranglehold On Ortho Devices Begins To Loosen
J&J, Smith & Nephew, Stryker, Zimmer Biomet and other companies in the orthopedic and spine surgery space have welcomed a recent rebound in orthopedic device demand, but the volume of elective knee surgeries is still behind its pre-pandemic level.
Orthopedic Roundup Q4: S&N, Stryker, J&J, Zimmer Biomet See Pandemic-Related Sales Impact
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
Market Brief: Extremity Replacement Market Expected To Reach $2Bn By 2024
Despite COVID-19, the market for extremity replacement implants looks healthy in the medium-term, with strong growth predicted as elective surgeries return.